Norac
Senior Scientist and Project Leader, Process R and D
Amri (Albany Molecular Research Inc.) May 2007 - Oct 2008
Senior Research Scientist Ii, Cgmp Kilo Lab
Amri (Albany Molecular Research Inc.) Mar 2004 - May 2007
Senior Research Scientist I, Api Process Development and Technology Transfer To Pilot Plant
Amri (Albany Molecular Research Inc.) Nov 2001 - Mar 2004
Senior Research Scientist, Chemical Development
Research Institute of Petroleum Processing Sinopec Jun 1987 - May 1991
Project and Group Leader
Education:
Michigan State University 2000 - 2001
University of Nebraska - Lincoln 1997 - 2000
Karlsruhe Institute of Technology (Kit) 1992 - 1997
Doctorates, Doctor of Philosophy, Organic Chemistry
Beijing University of Chemical Technology 1984 - 1987
Master of Science, Masters, Organic Chemistry
Beijing University of Chemical Technology 1980 - 1984
Bachelors, Bachelor of Science, Chemistry
Skills:
Technology Transfer Organic Chemistry Gmp Organic Synthesis Medicinal Chemistry Drug Discovery Process Simulation Formulation Hplc Chromatography Manufacturing Design of Experiments Lc Ms Cgmp English Drug Design Ir Nmr Glp German Chinese Lead Change Purification Controlled Substances Ich Guidelines High Potent Compounds Facility Auditoring Material Outsourcing
Paul Bruzinski - Clifton Park NY, US Xuejun Liu - Arcadia CA, US Cameron Gibb - Delmar NY, US Pedro E. Hernandez-Abad - Arroyo PR, US
International Classification:
C07H 19/16 C07H 1/00
US Classification:
536 276, 536 553
Abstract:
The present disclosure provides a method for the synthesis of IB-MECA. More specifically, the present disclosure provides a simple and high yield method for Good Manufacturing Production (GMP) of IB-MECA. The method involves the reaction of 6-halopurine-9-riboside with a diol protecting reagent; oxidation of the primary alcohol in the diol protected 6-halopurine-9-riboside with a diol protecting reagent; oxidation of the primary alcohol in the diol protected 6-halopurine; reaction of the diol protected 6-halopurine with a nucleophile (e.g. methylamine); substitution of the halogen group with iodobenzylamine and removal of the diol protecting group.
Process For Preparing An Enantiomerically Enriched, Deuterated Secondary Alcohol From A Corresponding Ketone Without Reducing Deuterium Incorporation
Ramanaiah C. Kanamarlapudi - Bridgewater NJ, US Steven A. Weissman - Short Hills NJ, US Emerich Eisenreich - Claremont CA, US Xuejun Liu - Arcadia CA, US
Assignee:
CONCERT PHARMACEUTICALS, INC. - Lexington MA
International Classification:
C12P 17/18
US Classification:
435119
Abstract:
The present invention provides a process for the preparation of enantiomerically enriched, deuterated secondary alcohols of Formula 1-A by employing ketoreductases or carbonyl reductases without reducing deuterium incorporation.
Process For Preparing An Enantiomerically Enriched, Deuterated Secondary Alcohol From A Corresponding Ketone Without Reducing Deuterium Incorporation
Ramanaiah C. Kanamarlapudi - Bridgewater NJ, US Steven A. Weissman - Short Hills NJ, US Emerich Eisenreich - Claremont CA, US Xuejun Liu - Arcadia CA, US
Assignee:
CONCERT PHARMACEUTICALS, INC. - Lexington MA
International Classification:
C12P 17/18
US Classification:
435119
Abstract:
The present invention provides a convenient and efficient process for the preparation of enantiomerically enriched, deuterated secondary alcohols without reducing deuterium incorporation.
Synthesis Of 4-Chlorokynurenines And Intermediates
The invention relates to an overall enantio-specific synthesis of 4-chlorokynurenine compounds, in particular L-4-chlorokynurenine, with improved yields. Large-scale syntheses are disclosed. The invention also relates to novel intermediates in the synthesis of L-4-chlorokynurenine.
Glycopyrronium Fatty Acid Salts And Methods Of Making Same
- Canandaigua NY, US Emerich Eisenreich - Claremont CA, US Xuejun Karl Liu - Arcadia CA, US Bingidimi Itute Mobele - Altamont NY, US Satish Goud Puppali - Rancho Cucamonga CA, US
International Classification:
C07D 207/12 C07C 53/126 C07C 57/12 C07C 57/03
Abstract:
Novel glycopyrronium fatty acid salts have been developed. Bi-phasic reaction conditions enable the desired counterion exchange reactions between glycopyrronium bromide and fatty acid salts of alkali metals and alkaline earth metals in methods to form glycopyrronium fatty acid salts. In preferred embodiments, an excess of the free fatty acid in the reaction mixture stabilizes the glycopyrronium fatty acid salt and reduces the formation of the impurity, Acid A. In some preferred embodiments, between 0.2 and 1.2 molar equivalent of excess free fatty acid is added to the reaction mixture. In another embodiment, approximately 1.2 molar equivalent of excess free fatty acid is added to the reaction mixture.
Process For Preparing An Enantiomerically Enriched, Deuterated Secondary Alcohol From A Corresponding Ketone Without Reducing Deuterium Incorporation
- Lexington MA, US Steven A. Weissman - Short Hills NJ, US Emerich Eisenreich - Claremont CA, US Xuejun Liu - Arcadia CA, US
International Classification:
C12P 17/18 C07D 473/10
Abstract:
The present invention provides a process for the preparation of enantiomerically enriched, deuterated secondary alcohols of Formula 1-A by employing ketoreductases or carbonyl reductases without reducing deuterium incorporation.